Home Blog Page 1014

Yunji Technology: AI Agent Revenue Soars Nearly 3x, HDOS Clients Surge 925%

HONG KONG, March 17, 2026 /PRNewswire/ — Yunji Technology (2670.HK), China’s leading hospitality robotic-based AI agent company, delivered a strong debut annual report since its October 2025 listing on the Hong Kong Stock Exchange under Chapter 18C for specialist tech firms.


In 2025, the company reported revenue of RMB 301 million (+23.1% YoY), with gross profit reaching RMB 113 million.

A key highlight was the rapid shift toward a “hardware-software integrated” model. While robot and accessory sales remained the core at RMB 213 million (+12.9%), AI digital systems revenue surged 57.3% to RMB 87.9 million, now accounting for 29.2% of total income. Within this segment, AI-driven agent application revenue exploded by 194.1% to RMB 33.9 million, fueled by the rollout of its HDOS intelligent agent system. HDOS subscription clients skyrocketed from 237 to 2,430—a staggering 925% increase—validating market demand for embodied AI services.

Beyond its hotel stronghold—where revenue grew 20.1% to RMB 244 million across more than 40,000 properties globally—Yunji is successfully diversifying. Revenue from non-hotel sectors jumped 37.7%, led by tech facilities (+160.4%) and factories (+393%). Commercial buildings and hospitals also contributed meaningfully, with hospital deployments rising from 130 to ~200.

R&D spending exceeded RMB 60 million, maintaining a >20% R&D ratio to advance core algorithms and platform capabilities. Analysts remain optimistic: CCB International noted in February 2026 that economies of scale should stabilize margins and reduce expense ratios over time.

According to Frost & Sullivan, China’s robotics service agent market is projected to grow at a 29.3% CAGR—from RMB 3.7 billion in 2024 to RMB 13.5 billion by 2029. As the category leader, Yunji is well-positioned to capture this expanding opportunity through real-world deployments, scalable technology, and recurring software revenue.

BILIGHT Concludes Japan PV EXPO 2026: Leading the “Powering AI” Era with Full-Scenario Perovskite Solutions

TOKYO, March 17, 2026 /PRNewswire/ — The three-day Asia photovoltaic event, PV EXPO 2026, concluded today at Tokyo Big Sight. BILIGHT, a global leader in flexible perovskite technology, delivered an impressive performance, securing preliminary cooperation agreements with numerous global partners across the industry.

A Strategic Vision: Powering the AI Evolution

In an era of accelerating artificial intelligence, BILIGHT has officially transitioned its brand vision to “Powering AI”. The company is building a comprehensive energy ecosystem spanning near-Earth orbit, high-altitude platforms, and ground-level edge computing. By closing the “Cloud-Network-Terminal-Edge” energy loop, BILIGHT provides stable, efficient, and sustainable power for the computing infrastructure, intelligent terminals, and autonomous systems that define the intelligent age.

Space-Grade Tech for Edge Intelligence

The star of the exhibition was the “Solar Wing” space-grade perovskite PV. This ultra-light, ultra-thin, and flexible technology solves critical power bottlenecks for AI edge computing devices and high-altitude unmanned systems operating in extreme environments. Industry experts noted that the “Solar Wing” offers a highly competitive solution for increasingly scarce urban commercial spaces.

From the Cosmos to Smart Living

BILIGHT also showcased its flexible rollable PV curtains, bringing space-grade technology down to earth. This product integrates high-performance cells into residential environments, providing autonomous power for smart home AI terminals. This “full-scenario coverage” proves that perovskite technology can power both the deep cosmos and daily domestic life.

Industry and Capital Recognition

The company’s performance attracted significant interest from global investors. Analysts believe BILIGHT’s ability to drive active energy perception and intelligent scheduling puts it at the forefront of the commercial race for perovskite technology.

As the expo concludes, BILIGHT is accelerating its mission of energy equality. By making clean energy as accessible as air, BILIGHT ensures that the intelligent era is built on a foundation of reliable, sustainable power.

Ribo to present ex-hepatic delivery data at RNA Leaders Europe Conference

SUZHOU, China and MÖLNDALS, Sweden, March 17, 2026 /PRNewswire/ — Suzhou Ribo Life Science Co., Ltd.  (“Ribo” or “the Company”, Hong Kong Stock Exchange code: 6938) has been invited to give a speech at the RNA Leaders Europe Conference in Vienna, Austria on March 19th, one of the top oligonucleotide conferences.

Following Ribo’s success of the RiboGalSTAR™ targeting liver specific genes with seven programs in clinical and two major global collaborations and licensing deals valued more than USD 6B, Ribo now continues its innovation journey towards the ex-hepatic space enabled by its proprietary delivery technology platform RiboPepSTAR™. The RiboPepSTAR™ platform enables targeted siRNA delivery to multiple critical organs beyond the liver. By using the platform, good performance in kidney delivery has been achieved, with preclinical data demonstrating proximal tubular specific uptake, and knockdown of mRNA levels cross-species from rodents to NHPs, and validation in various disease models.

In addition to kidney, more targeted drug candidates are under preclinical development to further extend the therapeutic reach to cardiac, adipose, muscle, and CNS disorders. Ribo will continue to advance ex-liver products in order to bring innovative siRNA therapeutics to patients worldwide.

Advantech to Showcase Edge AI and Physical AI Innovations at NVIDIA GTC 2026

Featuring robotics, medical AI, and industrial edge deployment powered by NVIDIA Jetson Thor

TAIPEI, March 17, 2026 /PRNewswire/ — Advantech (TWSE: 2395), a global leader in IoT intelligent systems and embedded platforms, announced it will participate in NVIDIA GTC 2026, taking place March 16–19 in San Jose, California. At Booth #1134 and Meeting Rooms #6077 and #6078, Advantech will showcase next-generation edge AI platforms and solutions powered by technologies from NVIDIA, including NVIDIA Jetson Thor and NVIDIA IGX Thor. The exhibit will highlight how physical AI and edge AI are enabling real-world deployment across robotics, medical systems, smart logistics, and intelligent retail environments. By integrating hardware platforms, AI development frameworks, and ecosystem partnerships, Advantech continues to help enterprises move efficiently from AI evaluation to scalable deployment at the edge.

Advantech AIR-075 (built on NVIDIA Jetson Thor), a visual AI platform designed to enable visual AI agents for safety monitoring and incident response.jpg
Advantech AIR-075 (built on NVIDIA Jetson Thor), a visual AI platform designed to enable visual AI agents for safety monitoring and incident response.jpg

Ween Niu, General Manager of Advantech North America, noted that as AI rapidly evolves, the industry is moving beyond cloud-based model training toward real-world, physical applications—often referred to as Physical AI. Advantech has long focused on edge computing and edge AI, building industrial-grade platforms designed for performance, reliability, and scalable deployment. At this year’s GTC, Advantech will demonstrate its close collaboration within the NVIDIA ecosystem, combining advanced hardware, software frameworks, and industry-ready solutions to accelerate AI adoption in robotics, medical devices, and smart environments while enabling faster deployment of Physical AI across industries.

Advancing robotics perception and humanoid robotics development

For robotics applications, Advantech will present robotics-ready edge AI platforms designed for rapid integration of sensors and multi-camera systems. The ASR-A702 / AFE-A702 (built on NVIDIA Jetson Thor) works with Advantech Robotic Suite and NVIDIA Isaac ROS to support key perception capabilities such as object detection, distance estimation, pose tracking, and VSLAM.

To support the next generation of humanoid robotics, the MIC-742 (built on NVIDIA Jetson Thor) delivers up to 2,070 TFLOPS (FP4) AI performance and can be paired with the NVIDIA Holoscan Sensor Bridge to enable an ultra-low-latency sensor-to-inference pipeline for transformer and vision-language-action models. These capabilities demonstrate how edge AI platforms can accelerate robotics innovation and real-world deployment through ecosystem collaboration.

Real-time medical imaging AI enabling intelligent surgical system

In healthcare, Advantech will showcase the AIMB-294 medical AI board (built on NVIDIA Jetson Thor), capable of performing real-time surgical instrument anomaly detection, organ segmentation, and AR overlay while operating at only 130W and without additional GPU modules. Combined with advanced medical AI frameworks and Advantech edge AI software tools, the platform supports low-latency imaging pipelines and streamlined AI model deployment, improving overall device performance and reliability.

Advantech will also highlight the USM-500, a medical-grade platform powered by NVIDIA IGX optimized for advanced AI-powered medical applications. The platform enables real-time multimodal sensor fusion and edge AI processing for AI-assisted surgery, intraoperative imaging, endoscopic video analytics, and robotic surgical guidance, delivering hospital-grade reliability and performance.

Visual AI agents and video intelligence for smart warehouses and logistics

To address the growing demand for intelligent logistics and warehouse management, Advantech will present the AIR-075 (built on NVIDIA Jetson Thor), a visual AI platform designed to enable visual AI agents for safety monitoring and incident response, with 10GbE connectivity supporting high-bandwidth video streaming.

Advantech will also demonstrate the MIC-743 (built on NVIDIA Jetson Thor) running advanced video search and summarization capabilities that enable real-time vision analytics, natural-language queries, and rapid video summarization. These technologies help enterprises improve operational visibility, efficiency, and decision-making across logistics environments.

Edge-based generative AI powering smart retail experiences

For retail and service environments, Advantech will feature the DS-015 (built on NVIDIA Jetson Orin) edge AI system running generative AI models through Advantech Edge AI SDK. The platform enables on-device large language model (LLM) interactions without relying on cloud connectivity, making it suitable for kiosks, smart retail stores, digital signage, and industrial edge deployments. This approach allows organizations to enhance customer engagement while maintaining low latency, data privacy, and operational reliability.

Advantech North America invites industry partners and customers to visit Booth #1134 and Meeting Rooms #6077 and #6078 at NVIDIA GTC 2026 to explore how Edge AI and Physical AI technologies can accelerate digital transformation and unlock new opportunities for real-world AI applications.

About Advantech

Advantech is a global leader in IoT intelligent systems and embedded platforms, with the corporate vision of “Enabling an Intelligent Planet.” Advantech North America, a subsidiary of Advantech Co., Ltd., is the company’s largest subsidiary and drives regional business growth, customer engagement, and ecosystem development. To embrace the trends of edge computing and artificial intelligence, Advantech fully deploys its sector-driven strategy and focus on Edge Computing and Edge AI, targeting five key markets: Edge Intelligence Systems, Manufacturing, Energy and Utilities, iHealthcare, and iCity Services & iRetail. In the meantime, Advantech is enhancing its global presence and core competitiveness by integrating its Edge Computing hardware platform, the WISE-IoT software platform, and sector-specific Edge AI solutions with domain expertise. The integration will form an “Orchestration” model for seamless industrial chain connections, benefiting both our partners and clients. Advantech is also working with business partners to co-create business ecosystems that accelerate the goal of industrial intelligence. (www.advantech.com)

Shoplazza Adopts Agentic Commerce Architecture to Power AI-Driven E-commerce Operations

TORONTO, March 17, 2026 /PRNewswire/ — Shoplazza, a global commerce platform serving direct-to-consumer (DTC) brands, today announced the adoption of an Agentic Commerce architecture across its platform, introducing AI agents that can directly execute operational tasks within e-commerce workflows.

Agentic commerce shifts e-commerce from tool-based management to goal-based execution. Instead of navigating multiple dashboards or configuring workflows step by step, merchants can simply describe the business outcome they want, and the platform coordinates the necessary actions across storefront operations, payments, marketing tools, and customer management systems. The platform can automatically execute tasks such as creating campaigns targeting specific customers, updating storefront merchandising, launching campaigns, and monitoring performance.

At the core of this capability is Shoplazza’s proprietary Ecom Agent orchestration layer, which coordinates how AI agents interact with the platform’s commerce systems. This infrastructure allows agents to securely access different parts of the platform and execute tasks across storefront management, payments, marketing, and customer data while maintaining merchant-defined permissions and safeguards. The platform also evaluates results using real transaction data, enabling the system to continuously improve how similar tasks are executed over time.

A recent industry report from 36Kr highlights Shoplazza as an example of how commerce platforms are evolving toward Agentic Commerce. The report notes that e-commerce infrastructure is moving beyond traditional SaaS platforms to AI-enabled systems that can automate operational tasks and assist merchants in running day-to-day commerce activities.

“E-commerce is entering its deepest waters. The merchants who survive aren’t looking for more tools; they need an intelligent co-pilot,” said Jeff Li, Founder and CEO of Shoplazza. “That’s why we’re building end-to-end AI agents that don’t just execute tasks, but think, analyze, and optimize across the entire customer journey.”

Founded in 2017, Shoplazza provides global commerce infrastructure that enables businesses to build and operate online stores while coordinating payments, marketing, fulfillment, and customer operations within a unified platform. Today, the platform supports more than 650,000 merchants serving consumers in over 180 countries and regions, and operates within an ecosystem of more than 500 global partners.

About Shoplazza

Shoplazza is a Canadian commerce infrastructure platform that enables global businesses to build, launch, and scale their online stores. Built with an agentic commerce architecture, the platform integrates storefront technology, payments, marketing tools, and operational intelligence to support merchants operating across multiple markets. Learn more at https://www.shoplazza.com/.

 

Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/VEGFR2 Bispecific ADC JSKN027

SUZHOU, China, March 17, 2026 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the phase I clinical study (study code: JSKN027-101) of JSKN027, an independently developed innovative bispecific antibody-drug conjugate (ADC) targeting PD-L1 and VEGFR2, for the treatment of advanced malignant solid tumors. JSKN027 is the company’s fifth ADC candidate entering clinical development, as well as the world’s first PD-L1/ VEGFR2 bispecific ADC to advance into clinical trials.

As the global burden of malignant tumors continues to rise, there is an urgent clinical need for more effective and innovative therapies applicable across various tumor types. PD-L1 is a key molecule in regulating immune responses, and VEGFR2 is a core signaling hub in tumor angiogenesis. Within the immunosuppressive microenvironment of various solid tumors, the VEGF/VEGFR signaling pathway and the PD-1/PD-L1 axis exhibit a synergistic interplay, collectively driving immune evasion and providing a new strategy for dual-target therapy. JSKN027 is an innovative bispecific ADC designed based on this synergistic mechanism. By leveraging glycan-specific conjugation technology, it precisely links its cleavable linker and topoisomerase I inhibitor payload to the antibody’s Fc region. This design confers multiple mechanisms of action, including targeted chemotherapy, anti-angiogenesis and immunotherapy. It is expected to synergistically enhance antitumor efficacy and overcome therapeutic resistance, offering a promising treatment strategy across solid tumors.

JSKN027-101 is an open-label, multi-center, Phase I clinical study, including dose-escalation and dose-expansion phases. This study aims to evaluate the safety, tolerability, pharmacokinetics (PK)/pharmacodynamics (PD), and antitumor activity of JSKN027 in patients with advanced malignant solid tumors, and determine the maximum tolerated dose (MTD) and/or recommended Phase II dose (RP2D).

About JSKN027

JSKN027 is a first-in-class bispecific ADC designed to co-engage PD-L1 and VEGFR2. By leveraging glycan-specific conjugation technology, it precisely links its cleavable linker and topoisomerase I inhibitor payload to the antibody’s Fc region – maintaining a strong safety profile while unlocking potent anti-tumor activity.

JSKN027’s efficacy stems from a unique three-fold synergistic mechanism. Beyond the standard ADC effects of targeted cell killing and bystander activity, it also inhibits tumor angiogenesis by blocking VEGF/VEGFR2 signaling and reverses immune suppression by disrupting the PD-1/PD-L1 checkpoint. This integrated attack enhances overall anti-tumor power and is anticipated to help overcome therapeutic resistance. As a result, JSKN027 is poised to offer a novel and robust treatment avenue for patients across multiple solid tumor types. The Phase I clinical study of JSKN027 in patients with advanced malignant solid tumors has been conducted in China.

About Alphamab Oncology

Alphamab Oncology (Stock Code: 9966.HK) is an innovative biopharmaceutical company focused on oncology. Leveraging proprietary platforms including single-domain antibodies, bispecific antibodies, glycan-specific conjugation, linker-payloads, dual-payload ADCs, and high-concentration subcutaneous formulations, the Company has built a differentiated and globally competitive pipeline, covering cutting-edge candidates in ADCs, bispecific antibodies, and single-domain antibodies.

One product has received market approval: Envafolimab (KN035, brand name: 恩维达®), the world’s first subcutaneously injected PD-(L)1 inhibitor, offering greater convenience and accessibility in cancer treatment. The NMPA has accepted the new drug application for KN026 (Anbenitamab Injection), a HER2 bispecific antibody, for second-line or later HER2-positive gastric cancer. Five bispecific ADC candidates have entered clinical stages, and next-generation ADC pipelines—such as dual-payload ADCs—are advancing rapidly. The Company has established strategic partnerships with organizations including CSPC, ArriVent, and Glenmark, covering both product development and technology platforms.

Our overarching mission is to make cancer manageable and curable by addressing unmet clinical needs in oncology. Alphamab Oncology is continuously dedicated to the development of effective, safe, and globally competitive anti-tumor drugs, enabling patients to achieve long-term, high-quality survival and delivering China-innovated cancer therapies to benefit patients worldwide.

Mitrade Secures Five Global Industry Awards in 2026 as Asia Traders Reassess Counterparty Risk

KUALA LUMPUR, Malaysia, March 17, 2026 /PRNewswire/ — CFD broker Mitrade announced five awards, positioning the recognition against a backdrop of heightened volatility and monetary divergence across the region.

The US-Iran conflict and Tehran’s leadership transition have pushed oil past $109, rocking global markets. Asian equities face energy and shipping disruptions. A resurgent US dollar has strained the Vietnamese dong and pushed the Indonesian rupiah toward Rp17,000, while regional currencies track widening policy divergence.

For leveraged CFD traders, these conditions often result in shorter positioning cycles and increased margin sensitivity. Rising retail participation has also sharpened focus on broker credibility and overall financial safeguards.

Since 2025, Mitrade has provided aggregate client fund insurance coverage of up to US$1 million for clients onboard under its CIMA and FSC-regulated entities, later extended to include its FSCA-regulated entity. The coverage provides protection for eligible clients in the unlikely event of broker insolvency.

Kevin Lai, Vice President of Mitrade Group, said operational stability and fund safety are central to trading decisions in the region.

“In complex market conditions, traders assess both price direction and the resilience of the institutions they use,” Lai said. “At Mitrade, adherence to client money rules, independent audits and insurance coverage reflect the standards traders increasingly expect when choosing a broker.”

In 2026, Mitrade secured five industry awards:

  • Best Broker MENA 2026 — World Business Outlook
  • Best Multi-Asset Trading 2026 — FX Daily Info
  • Best Broker Education Global 2026 — International Business Magazine
  • Regulated Broker of the Year Global 2026 — International Business Magazine
  • Best CFD Broker Global 2026 — Global Business and Finance Magazine

The company said the recognition reflects its emphasis on trader education and providing market context through structured resources and analysis.

About Mitrade

Mitrade is a globally recognised, award-winning CFD trading platform licensed under the Cayman Islands’ CIMA (SIB1612446), Mauritius’s FSC (GB20025791), Australia’s ASIC (AFSL398528), South Africa’s FSCA (FSP 54842) and Cyprus’s CySEC (CIF438/23). The group democratises market access, connecting 6M+ traders to 900+ OTC derivatives, including indices, forex, commodities, ETFs, and shares.

The platform offers millisecond execution, tight spreads, advanced risk mitigation, and multi-device compatibility, ensuring an intuitive trading experience tailored to every trader.

Trading involves risks. This article is for informational purposes only and not financial advice, an offer, or a solicitation.

Visit https://www.mitrade.com for more information.

 

Video series features CPPCC members’ insights on China’s next development stage

BEIJING, March 17, 2026 /PRNewswire/ — A special video series produced by the China Daily Opinion Channel during the annual two sessions brings together perspectives from five national political advisers on priorities for the 15th Five-Year Plan (2026-30) period.

Featuring interviews with five members of the 14th National Committee of the Chinese People’s Political Consultative Conference — Huang Qunhui, Jiang Ying, Dai Bin, Feng Li and Xu Jiuping — the series examines how China can advance high-quality growth, strengthen cultural vitality and cultivate future-ready talent.

Huang Qunhui, a researcher at the Institute of Economics, Chinese Academy of Social Sciences, emphasizes the role of developing “new quality productive forces” in supporting China’s modernization. He says China can draw on its institutional strengths, large market, industrial base and talent pool to upgrade traditional industries, expand domestic demand and proactively plan for emerging and future industries.

Jiang Ying, chair of Deloitte China, addresses the problem of excessive competition — often described as “involution”. She argues that the core issue is not competition itself, but that value is not fully reflected in pricing and market rules. During the next plan period, she calls for competition mechanisms guided by long-term value so that quality products, advanced technology and strong services can command fair prices. She also highlights sectors such as artificial intelligence and the low-altitude economy as key areas for breakthrough.

Dai Bin, president of the China Tourism Academy, discusses the recovery of inbound tourism and the popularity of “China Travel”. While facilitation has helped more visitors enter China, he notes that success depends on improving the experience after arrival. That includes developing new tourism resources, better mobilizing market players such as travel firms, and upgrading public services to encourage longer stays and deeper exploration.

Feng Li, president of the China National Opera & Dance Drama Theater, reflects on the arts as a source of cultural confidence. She stresses a people-centered approach and the importance of responding to the times. Citing the classic opera The White-Haired Girl, she says enduring works resonate because they tap universal emotions and renew themselves through sustained practice.

Xu Jiuping, a distinguished professor at Sichuan University, focuses on education in the AI era. While AI is reshaping industries and learning, he stresses that education must reinforce fundamental disciplines, language ability and critical thinking. Combining technological empowerment with humanistic knowledge, he says, is essential for nurturing innovative talent for the decade ahead.

https://www.chinadaily.com.cn/a/202603/12/WS69b79715a310d6866eb3e0ce.html